銀屑病治療市場規模、佔有率和成長分析：按治療方法、照光治療、系統療法、替代療法和地區分類——2026-2033年行業預測

2024 年全球乾癬治療市場價值為 16 億美元，預計從 2025 年的 17.4 億美元成長到 2033 年的 33.3 億美元，預測期（2026-2033 年）的複合年成長率為 8.5%。

全球銀屑病治療市場主要由創新治療方法驅動，尤其是生物目標和小分子化合物，這些療法顯著改善了疾病管理。該市場涵蓋多種治療方法，包括外用藥物、照光治療、全身用藥和新型口服療法，旨在解決影響患者生活品質的慢性發炎及相關合併症。市場正從傳統皮質類固醇轉向先進的IL-17和IL-23抑制劑，生物相似藥的出現影響定價和市場接受度。關鍵成長要素包括治療可近性的提高、新藥的核准以及服務不足人口對更佳治療方法的需求，所有這些都在推動市場擴張。此外，數位醫療的進步正在加速診斷並改善患者照護，而新型治療方法的持續研發也創造了強勁的投資機會，這表明銀屑病治療領域具有持續成長的潛力。

全球銀屑病治療市場促進因素

生物製藥療法的持續進步正在改變乾癬的治療格局，其特有的作用機制能夠改善臨床療效和患者的整體生活品質。更清晰的患者反應模式和更完善的安全監測提升了醫療專業人員對這些療法的投入，並促進了更廣泛的處方實踐。此外，製藥公司的大量投資和策略合作正在推動各種生物製藥及其製劑形式的研發，以滿足不同患者群體的需求，並促進市場進一步整合。因此，生物製藥的可近性和接受度不斷提高，推動了其在各種醫療機構中的應用，從而帶動了整體市場的強勁成長。

全球銀屑病治療市場面臨的限制因素

全球銀屑病治療市場面臨許多挑戰，包括治療費用高昂和患者就醫管道有限，這些都阻礙了先進治療方法的推廣應用。在保險報銷選擇有限且自付費用高昂的情況下，患者往往會因經濟原因而延後或放棄建議的治療方案。保險公司通常會設定嚴格的合格標準，進一步縮小了能夠接受這些治療的患者群體。因此，這些就醫障礙導致醫療服務提供者在開立昂貴治療方法時猶豫不決，阻礙了市場成長。最終，這將導致市場需求下降，創新解決方案的採納率降低。

全球銀屑病治療市場趨勢

全球銀屑病治療市場正經歷著向數位化醫療整合的重大轉變，其特點是遠距皮膚科會診和先進數位平台的日益普及。這一趨勢正在革新治療路徑，實現遠端患者監護、虛擬會診和人工智慧驅動的皮損評估，從而提高患者參與度和治療依從性。製藥公司正擴大建立策略合作夥伴關係，將數位工具整合到治療方案中，這加速了真實世界數據（REW）的收集，並支持分散式研究工作。因此，銀屑病治療領域湧現出新的機遇，可用於差異化的患者支援服務、基於價值的合約以及個人化的長期管理策略。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球銀屑病治療市場規模：依治療類別分類

• 生物治療
  • TNF抑制劑
  • IL抑制劑
• 局部治療
  • 皮質類固醇
  • 維生素D類似物

全球銀屑病治療市場規模：按光療類別分類

• UVB治療
  • 寬頻 UVB
  • 窄頻UVB
• PUVA療法
  • 甲氧沙林
  • 光活化療法

全球銀屑病治療市場規模：依系統治療分類

• 胺基甲基葉酸
  • 口服製劑
  • 注射藥物
• Cyclosporine
  • 口服製劑
  • 注射藥物

全球銀屑病治療市場規模：依替代療法分類

• 飲食療法
  • 抗發炎飲食
  • 排除飲食法
• 草藥療法
  • 蘆薈
  • 苦楝樹油

全球銀屑病治療市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Amgen Inc.
• Novartis
• AbbVie
• Janssen Pharmaceuticals
• Pfizer Inc.
• Eli Lilly and Company
• Regeneron Pharmaceuticals
• Galderma
• Boehringer Ingelheim
• Sun Pharmaceuticals
• UCB SA
• Dermavant Sciences
• Celgene Corporation
• Athenex, Inc.
• Merck & Co.
• Sandoz
• Valeant Pharmaceuticals
• ReniAqua
• Almirall SA
• Incyte Corporation

結論與建議

Global Psoriasis Treatment Market size was valued at USD 1.6 Billion in 2024 and is poised to grow from USD 1.74 Billion in 2025 to USD 3.33 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global psoriasis treatment market is primarily driven by innovative therapeutics, particularly targeted biologics and small molecules that significantly enhance disease management. This market includes a variety of treatments like topical agents, phototherapy, systemic medications, and emerging oral therapies, addressing chronic inflammation and related comorbidities, which impact quality of life. The market has shifted from traditional corticosteroids to advanced IL-17 and IL-23 inhibitors, with biosimilars influencing pricing and adoption trends. Key growth factors involve increased access, new regulatory approvals, and the need for improved treatments in underserved populations, fostering market expansion. Additionally, digital health advancements are accelerating diagnoses, enhancing patient care, while ongoing R&D in novel therapies presents robust investment opportunities, promising sustainable growth potential for the psoriasis treatment sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Psoriasis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Psoriasis Treatment Market Segments Analysis

Global psoriasis treatment market is segmented by drug-based treatments, phototherapy treatments, systemic treatments, alternative treatments and region. Based on drug-based treatments, the market is segmented into Biologic Treatments and Topical Treatments. Based on phototherapy treatments, the market is segmented into UVB Treatment and PUVA Treatment. Based on systemic treatments, the market is segmented into Methotrexate and Cyclosporine. Based on alternative treatments, the market is segmented into Dietary Changes and Herbal Remedies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Psoriasis Treatment Market

The ongoing advancement of biologic therapies has transformed the landscape of psoriasis treatment, providing specific mechanisms that enhance clinical results and overall quality of life for patients. The inclination of healthcare professionals towards these therapies, bolstered by clearer patterns of patient responses and enhanced safety monitoring, promotes wider prescription practices. Additionally, significant investment from pharmaceutical companies and strategic collaborations contribute to the development of a diverse range of biologic agents and formulations, which cater to various patient demographics and facilitate deeper market integration. Consequently, the increasing availability and acceptance of biologics drive their use across various healthcare settings, fostering robust growth in the overall market.

Restraints in the Global Psoriasis Treatment Market

The global psoriasis treatment market faces significant obstacles due to high treatment costs and restricted patient access, which hinder the widespread adoption of advanced therapies. In environments where reimbursement options are limited or out-of-pocket expenses are high, patients often delay or abandon recommended treatments due to financial concerns. Payers frequently implement stringent eligibility criteria, further narrowing the pool of patients who can receive these therapies. As a result, these access challenges deter healthcare providers from prescribing expensive treatments and impede market growth, ultimately leading to diminished demand and a slower adoption rate of innovative solutions within the market.

Market Trends of the Global Psoriasis Treatment Market

The Global Psoriasis Treatment market is witnessing a significant shift towards digital care integration, characterized by the growing adoption of teledermatology and advanced digital platforms. This trend is revolutionizing treatment pathways by enabling remote patient monitoring, virtual consultations, and AI-driven lesion assessments, thus enhancing patient engagement and adherence to treatment. Pharmaceutical companies are increasingly forming strategic partnerships to incorporate digital tools into their treatment programs, facilitating the collection of real-world evidence and supporting decentralized research efforts. As a result, there are emerging opportunities for differentiated patient support services, value-based contracting, and personalized long-term management strategies within the psoriasis treatment landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Psoriasis Treatment Market Size by Drug-Based Treatments & CAGR (2026-2033)

• Market Overview
• Biologic Treatments
  • TNF Inhibitors
  • IL Inhibitors
• Topical Treatments
  • Corticosteroids
  • Vitamin D Analogues

Global Psoriasis Treatment Market Size by Phototherapy Treatments & CAGR (2026-2033)

• Market Overview
• UVB Treatment
  • Broadband UVB
  • Narrowband UVB
• PUVA Treatment
  • Methoxsalen
  • Photoactivated Therapy

Global Psoriasis Treatment Market Size by Systemic Treatments & CAGR (2026-2033)

• Market Overview
• Methotrexate
  • Oral Formulation
  • Injectable Formulation
• Cyclosporine
  • Oral Formulation
  • Injection Formulation

Global Psoriasis Treatment Market Size by Alternative Treatments & CAGR (2026-2033)

• Market Overview
• Dietary Changes
  • Anti-inflammatory Diet
  • Elimination Diet
• Herbal Remedies
  • Aloe Vera
  • Neem Oil

Global Psoriasis Treatment Market Size & CAGR (2026-2033)

• North America (Drug-Based Treatments, Phototherapy Treatments, Systemic Treatments, Alternative Treatments)
  • US
  • Canada
• Europe (Drug-Based Treatments, Phototherapy Treatments, Systemic Treatments, Alternative Treatments)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug-Based Treatments, Phototherapy Treatments, Systemic Treatments, Alternative Treatments)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug-Based Treatments, Phototherapy Treatments, Systemic Treatments, Alternative Treatments)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug-Based Treatments, Phototherapy Treatments, Systemic Treatments, Alternative Treatments)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Janssen Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dermavant Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athenex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valeant Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReniAqua
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almirall S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incyte Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations